INR:0819. ludo dice png AbbVie's JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis Vitrakvi, the first "broad-spectrum" anticancer drug that ...
INR:9435. rohit sharma qualification Research on the development of biopharmaceutical industry in Lianyungang AbbVie's JAK inhibitor approved for psori ...
INR:8206. football game timing R&D Daily丨Novartis's Secukinumab for the treatment of ankylosing spondylitis is about to be approved in China Guangshengtang ...
Evropa bet Ascletis's clinical trial application for a Class 1 innovative drug for non-alcoholic steatohepatitis has been accepted Novartis's secukinumab for ...
INR:3599. bet99 review New company challenging CRISPR technology raises $34 million in Series A funding AbbVie's JAK inhibitor approved for psoriatic arthritis and a ...
INR:4887. monkey warrior art Sci Transl Med: Scientists reveal genetic cause of primary sclerosing cholangitis The Lancet: Viral load is the main driving force ...
Lucky Bets Casino The first domestically produced third-generation EGFR-TKI ametinib mesylate tablets are about to be approved Novartis's secukinumab ...